Delivery Order SPE2DB22D1106-SPE2DB24FELH3
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $7.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,637.74, is for the delivery of the medication RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $7,320.96, is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,245.30, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
- This is a $47,186.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. There is no set-aside designation for this contract. AmerisourceBergen, a major pharmaceutical distributor, is providing these medications to support military treatment facilities and other federal healthcare programs. This delivery order is part...
- This is a $41,420.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of RINVOQ ER 30 MG TABLET UU 30S, a specialty medication, to support federal healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $4,372.44, is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a prescription pharmaceutical product. The delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of medical commodities to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,820.45, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a final completion date of May 13, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999 through December 2025, is for the supply of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide. The specific delivery order, valued at $7,068.48, is for the supply of RINVOQ ER 15 MG TABLET, a...
- This is a $7,677.19 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication RINVOQ ER 30 MG TABLET UU 30S, with a period of performance ending on July 3, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical,...
- This is a $14,547.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a prescription pharmaceutical product, with an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FELH3Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,456.13 delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen Drug Corp to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide. The delivery order does not have a set-aside designation.
Generated 7/12/24, 10:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 4/12/24 |